Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/14/11 → 7/14/17 |
Funding
- INC Research, LLC (CC-10004-PSOR-009)
- Celgene Corporation (CC-10004-PSOR-009)
Prot# CC-10004-PSOR-009: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects with Moderate to Severe Plaque Psoriasis
- Laumann, Anne E (PD/PI)
- Singri, Prashant (Co-PD/PI)
Project: Research project